Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

PeerView Oncology
Avatar

2020 Updates on Immuno-Oncology: A Visual Exploration of Current and Emerging Pathways, Targets, and Biomarkers to Maximize the Potential of Cancer Immunotherapies

By PeerView Oncology FEATURING Nadeem Riaz
By PeerView Oncology FEATURING Nadeem Riaz
0 views
November 27, 2020
Comments 1
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
General Oncology
30:53
Beth Israel Deaconess Medical Center

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Feat. M. Van Den Brink
54:05
Masonic Cancer Center, University of Minnesota

The Innate and Adaptive Responses of NK Cells

Feat. J. Sun
09:48
ecancer

ESMO 2022 on the PATHFINDER Study: A New Era of Early Cancer Detecti…

Feat. D. Schrag
44:01
Memorial Sloan Kettering Cancer Center

The Impact of Access to Care on HPV-Associated Cancer Disparities: L…

Feat. A. Aragones
08:08
The Asian Oncology Society 1st Virtual International Conference

Clinically Actionable Genomic Drivers: Which Cancers Are on the Rise?

Feat. A. Drilon
08:18
The Asian Oncology Society 1st Virtual International Conference

The Diagnostic Migration Towards Comprehensive Sequencing Approaches…

Feat. A. Drilon
09:42
The Asian Oncology Society 1st Virtual International Conference

Contemporary Comprehensive Sequencing Platforms: What Are the Advant…

Feat. A. Drilon
12:18
Beacon Medical Interchange

Clinical Research and the Changing Practice of Managing Narrow Subgr…

Feat. A. Drilon, J. West
19:37
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Managing Pneumonitis and other Rare/Lethal Side Effects of Immunothe…

Feat. M. Postow
19:15
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Immune Related Adverse Events (irAE) From Checkpoint Inhibitor Immun…

Feat. M. Postow
21:32
PeerView Oncology

2020 Updates on Immuno-Oncology: A Visual Exploration of Current and…

Feat. N. Riaz